Estee Lauder Q4 sales up 5%; raises FY27 margin outlook to 12.7%-13.5%
Estee Lauder reported Q4 FY26 organic sales growth of 5% and adjusted EPS of $0.39, beating estimates. The company raised its FY27 adjusted operating margin outlook to 12.7%-13.5%, citing strong momentum in Skin Care and Fragrance.

*this image is generated using AI for illustrative purposes only.
The Estée Lauder Companies Inc. (NYSE: EL) reported fiscal fourth-quarter 2026 results that exceeded Wall Street expectations, with adjusted diluted net earnings per share rising to $0.39 from $0.09 in the prior-year period. This result beat the analyst consensus estimate of $0.32 by 21.88%. Quarterly reported net sales increased 6% to $3.627 billion, surpassing the analyst estimate of $3.543 billion, while organic net sales grew 5%. CEO Stéphane de La Faverie stated that the company had "reignited growth," marking a fourth straight quarter of organic sales acceleration.
Fourth Quarter Highlights
For the three months ended June 30, 2026, growth was broad-based across all product categories except Hair Care and all geographic regions. The Middle East conflict reduced consolidated sales growth by approximately 1 percentage point and cut Europe, U.K., and emerging markets (EUKEM) growth by about 2 percentage points. However, these disruptions were more than offset by benefits from tariff refunds received, which contributed $.07 per share compared to a $.05 dilutive impact from the conflict.
Net loss for the quarter was $116 million, or $.32 per diluted share, compared to a net loss of $546 million, or $1.51 per diluted share, in the prior-year period. Restructuring and other charges resulted in an unfavourable impact of $306 million ($258 million net of tax), equal to $.71 per diluted share.
Full-Year Financial Performance
The following table summarises key fiscal 2026 and fiscal 2025 financial metrics for the year ended June 30.
| Metric: | FY2026 | FY2025 | Change |
|---|---|---|---|
| Net Sales: | $15,049 million | $14,326 million | +5% |
| Organic Net Sales (Non-GAAP): | $14,811 million | $14,323 million | +3% |
| Gross Profit: | $11,362 million | $10,597 million | +7% |
| Gross Margin: | 75.5% | 74.0% | — |
| Adjusted Gross Profit (Non-GAAP): | $11,372 million | $10,602 million | +7% |
| Adjusted Gross Margin (Non-GAAP): | 75.5% | 74.0% | — |
| Operating Income (Loss): | $780 million | $(785) million | 100+% |
| Operating Margin: | 5.2% | (5.5)% | — |
| Adjusted Operating Income (Non-GAAP): | $1,687 million | $1,146 million | +47% |
| Adjusted Operating Margin (Non-GAAP): | 11.2% | 8.0% | — |
| Diluted Net EPS: | $.50 | $(3.15) | 100+% |
| Adjusted Diluted Net EPS (Non-GAAP): | $2.51 | $1.51 | +66% |
Gross margin and adjusted gross margin both expanded 150 basis points to 75.5%, reflecting net benefits from the company's Profit Recovery and Growth Plan (PRGP). This expansion was partially offset by inflation and the impact of incremental tariffs net of refunds received. The prior-year operating loss was unfavourably impacted by $1,286 million of goodwill and other intangible asset impairments and $159 million of aggregate charges associated with talcum litigation settlement agreements.
Cash Flow and Balance Sheet
For the year ended June 30, 2026, cash and cash equivalents increased to $3,498 million from $2,921 million. Key cash flow highlights include:
- Net cash flows provided by operating activities increased 39% to $1,773 million from $1,272 million in the prior year, primarily reflecting higher net earnings excluding non-cash items.
- Capital expenditures decreased to $457 million from $602 million, with over 75% of total capital expenditures directed toward consumer-facing investments.
- Free Cash Flow was $1,316 million, compared with $670 million in the prior year.
- The company paid $300 million in deferred consideration associated with the fiscal 2023 acquisition of the TOM FORD brand and $508 million in dividends.
Results by Product Category
The table below reflects full-year net sales and operating income by product category for the year ended June 30.
| Category: | Net Sales FY2026 | Net Sales FY2025 | Reported Change | Organic Change | Op. Income FY2026 | Op. Income FY2025 |
|---|---|---|---|---|---|---|
| Skin Care: | $7,338 million | $6,962 million | +5% | +4% | $1,416 million | $574 million |
| Makeup: | $4,276 million | $4,205 million | +2% | Flat | $(70) million | $(441) million |
| Fragrance: | $2,779 million | $2,491 million | +12% | +10% | $204 million | $(378) million |
| Hair Care: | $565 million | $565 million | Flat | (1)% | $(4) million | $(41) million |
| Other: | $103 million | $100 million | +3% | +3% | $57 million | $(13) million |
- Skin Care organic net sales increased 4%, driven by La Mer, The Ordinary, and Estée Lauder. Adjusted operating income increased 52%.
- Makeup organic net sales were virtually flat, with growth from M·A·C and TOM FORD offset by declines from Bobbi Brown and Too Faced. Makeup net sales growth improved over 500 basis points compared to the prior year.
- Fragrance organic net sales increased 10%, led by double-digit growth from Le Labo, TOM FORD, and KILIAN PARIS. Adjusted operating income increased 27%.
- Hair Care organic net sales decreased 1%, driven by a decline from Aveda largely offset by growth from The Ordinary. Adjusted operating results improved to income from a loss in the prior year.
Results by Geographic Region
The table below reflects full-year net sales and operating income by geographic region for the year ended June 30.
| Region: | Net Sales FY2026 | Net Sales FY2025 | Reported Change | Organic Change | Op. Income FY2026 | Op. Income FY2025 |
|---|---|---|---|---|---|---|
| The Americas: | $4,463 million | $4,410 million | +1% | +1% | $211 million | $(818) million |
| EUKEM: | $3,794 million | $3,566 million | +6% | +1% | $196 million | $145 million |
| Asia/Pacific: | $3,746 million | $3,606 million | +4% | +4% | $823 million | $180 million |
| Mainland China: | $3,058 million | $2,741 million | +12% | +9% | $373 million | $194 million |
Organic net sales grew across all geographic regions. Mainland China delivered high-single-digit organic net sales growth, driven by innovation and existing products during key shopping moments, with strong double-digit growth across online distribution channels. The Americas returned to growth, led by North America, supported by major campaigns and increased consumer-facing investments. The region also benefited from an $18 million gain tied to the reversal of liabilities for unused gift cards. Adjusted operating income rose 17% in The Americas, 35% in EUKEM, 48% in Asia/Pacific, and 92% in Mainland China.
What the Numbers Show
The Q4 beat on both top-line and bottom-line metrics underscores the effectiveness of the company's cost-cutting measures amidst tariff headwinds. While incremental tariffs impacted gross margins by $102 million for the full year, the receipt of $38 million in refunds during Q4 helped mitigate this pressure. Furthermore, the swing from an operating loss of $(785) million in FY25 to an operating income of $780 million in FY26 highlights the significant contribution of the Profit Recovery and Growth Plan, which delivered $1.2 billion in gross benefits. The company expects stronger growth in the first half of fiscal 2027, helped by earlier product launches, higher travel retail shipments, and easier comparisons.
Profit Recovery and Growth Plan
The company concluded approvals relating to the restructuring component of the PRGP as of June 30, 2026. Key achievements include:
- Total gross benefits of $1.2 billion, at the high-end of the previously communicated range.
- Total net reduction of approximately 10,000 positions, at the high-end of the previously communicated range, enabling a 50% increase in productivity across corporate-function employees.
- Total cumulative charges slightly above the high-end of the previously communicated range of $1.5 billion to $1.7 billion.
- Full-year gross margin expansion of 150 basis points in fiscal 2026, with expansion in each quarter.
- Full-year adjusted operating margin expansion of 320 basis points, with expansion of nearly 300 basis points or more in each quarter.
Through June 30, 2026, the company recognised total cumulative charges under the restructuring component of the PRGP of $1.4 billion, consisting primarily of employee-related costs. In fiscal 2026, for the fourth quarter and full year, the company recognised charges of $0.3 billion and $0.8 billion, respectively. Actions under the PRGP are still expected to be substantially completed in fiscal 2027.
Fiscal 2027 Outlook
The company affirmed its fiscal 2027 organic net sales growth guidance of 3% to 5% and raised its adjusted operating margin outlook to 12.7% to 13.5%, up from a preliminary outlook of 12.5% to 13.0% communicated in May 2026. Forecasted adjusted diluted net earnings per common share for fiscal 2027 is $3.10 to $3.35, representing growth of 24% to 34% from fiscal 2026's $2.51. This compares with the $3.18 analyst estimate. Forecasted adjusted constant currency diluted net earnings per common share is $3.06 to $3.31, representing growth of 22% to 32%.
Key fiscal 2027 assumptions include an adjusted effective tax rate in the range of approximately 33% to 34%, diluted weighted-average shares outstanding of approximately 368 million shares, net cash flows provided by operating activities of between $1.3 billion and $1.4 billion, and capital expenditures of approximately 4% of projected sales. The company projects fiscal 2027 sales of $15.50 billion to $15.80 billion, compared with the $15.56 billion analyst estimate. Estée Lauder does not currently expect the Middle East conflict to materially affect fiscal 2027 results.
Quarterly Dividend
The company announced a quarterly dividend of $.35 per share on its Class A and Class B Common Stock, payable in cash on September 15, 2026 to stockholders of record at the close of business on August 31, 2026.
How might the completion of the Profit Recovery and Growth Plan in fiscal 2027 impact Estée Lauder's future capital allocation strategies, such as share buybacks or M&A activity?
Given the reliance on tariff refunds to offset margin pressure, what is the risk to fiscal 2027 margins if global trade policies shift and refund availability decreases?
Can the high-single-digit growth momentum in Mainland China be sustained given the increasing competition from domestic beauty brands and potential geopolitical headwinds?

































